As high court weighs Purdue bankruptcy, opioid settlement divides victims

A controversial aspect of the Purdue Pharma bankruptcy plan shields the owners from future lawsuits in exchange for the family’s contributing up to $6 billion.

View original article
Contributor: David Ovalle